AnaptysBio, Inc. (ANAB) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$33,014
Total Return
230.14%
CAGR
26.99%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +3.09% |
| Median | +2.21% |
| Best | +76.75% |
| Worst | -48.36% |
| % of Windows Positive | 57.2% |
1-Year (252 Trading Days)
| Average | +18.47% |
| Median | -7.51% |
| Best | +343.64% |
| Worst | -54.13% |
| % of Windows Positive | 35.0% |
3-Year (756 Trading Days)
| Average | +18.84% |
| Median | +8.95% |
| Best | +227.98% |
| Worst | -64.82% |
| % of Windows Positive | 55.2% |
Risk Metrics
| Maximum Drawdown | -69.32% |
| Average Drawdown | -30.46% |
| Drawdown Duration | 300 Trading Days |
| Sortino Ratio | 1.05 |
| Calmar Ratio | 0.39 |
| CVaR (5%) | -8.53% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +44.84% (+267.35% ann.) | +$4484.32 | $0.00 | $0.00 | $0.00 |
| 2025 | +266.16% | +$26616.30 | $0.00 | $0.00 | $0.00 |
| 2024 | -38.19% | $3818.86 | $0.00 | $0.00 | $0.00 |
| 2023 | -30.88% | $3088.09 | $0.00 | $0.00 | $0.00 |
| 2022 | -10.82% | $1082.02 | $0.00 | $0.00 | $0.00 |
| 2021 | +61.63% | +$6162.79 | $0.00 | $0.00 | $0.00 |
| 2020 | +32.31% | +$3230.78 | $0.00 | $0.00 | $0.00 |
| 2019 | -74.53% | $7452.58 | $0.00 | $0.00 | $0.00 |
| 2018 | -36.67% | $3666.60 | $0.00 | $0.00 | $0.00 |
| 2017 partial | +492.47% (+587.76% ann.) | +$49247.06 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | January 26, 2017 – February 19, 2020 | -8.65% | -2.91% | $864.71 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -20.12% | -92.31% | $2012.46 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +113.92% | +239.91% | +$11391.56 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +3.48% | +3.30% | +$347.74 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -9.46% | -10.01% | $945.90 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +22.95% | +11.79% | +$2295.08 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | +92.02% | +51.57% | +$9201.53 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.